5,8-Diaza-spiro[3.5]nonane-6-one hydrochloride
![5,8-Diaza-spiro[3.5]nonane-6-one hydrochloride price.](/CAS/GIF/1419101-36-2.gif)
|
- $1410 - $3036
- Product name: 5,8-Diaza-spiro[3.5]nonane-6-one hydrochloride
- CAS: 1419101-36-2
- MF: C7H13ClN2O
- MW: 176.64
- EINECS:
- MDL Number:MFCD23106420
- Synonyms:5,8-diazaspiro[3.5]nonan-6-one hydrochloride;5,8-Diaza-spiro[3.5]nonane-6-one hydrochloride;5,8-DIAZA-SPIRO[3.5]NONANE-6-ONE HCL;5,8-Diazaspiro[3.5]nonan-6-one, hydrochloride (1:1)
4 prices
Selected condition：
Brand
- Chemenu
- Crysdot
- Matrix Scientific
- Synthonix
Package
- 1g
- ManufacturerChemenu
- Product numberCM209092
- Product description5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95%
- Packaging1g
- Price$1681
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11261023
- Product description5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95+%
- Packaging1g
- Price$1784
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number123310
- Product description5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95+%
- Packaging1g
- Price$3036
- Updated2021-12-16
- Buy
- ManufacturerSynthonix
- Product numberD13166
- Product description5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95+%
- Packaging1g
- Price$1410
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM209092 | 5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95% | 1g | $1681 | 2021-12-16 | Buy |
| Crysdot | CD11261023 | 5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95+% | 1g | $1784 | 2021-12-16 | Buy |
| Matrix Scientific | 123310 | 5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95+% | 1g | $3036 | 2021-12-16 | Buy |
| Synthonix | D13166 | 5,8-Diaza-spiro[3.5]nonane-6-onehydrochloride 95+% | 1g | $1410 | 2021-12-16 | Buy |
Properties
CAS DataBase Reference :1419101-36-2
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|